BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22212937)

  • 1. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
    Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
    Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
    Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for hepatocellular carcinoma: how can we do better?
    Hassett M; Yopp AC; Singal AG
    Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
    Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for hepatocellular carcinoma.
    Sherman M
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
    Mok TS; Yeo W; Yu S; Lai P; Chan HL; Chan AT; Lau JW; Wong H; Leung N; Hui EP; Sung J; Koh J; Mo F; Zee B; Johnson PJ
    J Clin Oncol; 2005 Nov; 23(31):8041-7. PubMed ID: 16258102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis C and screening for hepatocellular carcinoma.
    Sherman M
    Clin Liver Dis; 2006 Nov; 10(4):735-52. PubMed ID: 17164115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
    Kee KM; Lu SN
    Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
    Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: evaluation of alpha-fetoprotein as a diagnostic marker.
    Songsivilai S; Dharakul T; Senawong S
    Asian Pac J Allergy Immunol; 1995 Dec; 13(2):167-71. PubMed ID: 8703246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: Where are we in 2018?
    Chapman WC; Korenblat KM; Fowler KJ; Saad N; Khan AS; Subramanian V; Doyle MBM; Dageforde LA; Tan B; Grierson P; Lin Y; Xu M; Brunt EM
    Curr Probl Surg; 2018 Nov; 55(11):450-503. PubMed ID: 30526875
    [No Abstract]   [Full Text] [Related]  

  • 17. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of screening methods for hepatocellular carcinomas in patients with cirrhosis.
    Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2979-82. PubMed ID: 11712797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.
    El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):441-3. PubMed ID: 23376321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.